STRO vs STZ · rev $62.0M vs P/E 14, rev $2.16B
Sutro Biopharma (STRO) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported STZ revenue for 2025-02-28 was $2.16B. Net income was -$375.3M. Revenue was up 1.2% from 2024-02-29 to 2025-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
STRO currently screens at market cap $470.8M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the STRO and STZ stock pages for the full models.
Not investment advice.